Alcon AG
ALC79.157USD
+0.357+0.45%
Market hours （ET）Quotes delayed by 15 min
39.15BMarket Cap
37.39P/E TTM
More Details of Alcon AG Company
Alcon AG is a Switzerland-based eye care company. The Company research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Company’s Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The Company operates in 60 countries and serves consumers and patients in over 140 countries.
Alcon AG Info
Ticker SymbolALC
Company nameAlcon AG
IPO dateApr 09, 2019
CEOEndicott (David J)
Number of employees25599
Security typeOrdinary Share
Fiscal year-endApr 09
AddressRue Louis d'Affry 6
CityFRIBOURG
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountrySwitzerland
Postal code1700
Phone41589113800
Websitehttps://www.alcon.ch/
Ticker SymbolALC
IPO dateApr 09, 2019
CEOEndicott (David J)
Company Executives of Alcon AG
Name
Name/Position
Position
Shareholding
Change
Mr. David J. Endicott
Mr. David J. Endicott
Chief Executive Officer, Director
Chief Executive Officer, Director
207.11K
-11.08%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
134.23K
+38.34%
Mr. Rajkumar Narayanan
Mr. Rajkumar Narayanan
Senior Vice President, President - International
Senior Vice President, President - International
37.83K
+9.30%
Mr. Ian Bell
Mr. Ian Bell
Chief Operating Officer, Senior Vice President
Chief Operating Officer, Senior Vice President
30.23K
-24.88%
Ms. Karen J. May, CPA
Ms. Karen J. May, CPA
Independent Director
Independent Director
28.32K
+11.14%
Mr. Laurent Attias
Mr. Laurent Attias
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
22.62K
+15.19%
Mr. Scott Harlan Maw
Mr. Scott Harlan Maw
Independent Director
Independent Director
17.26K
+14.57%
Ms. Ines Poeschel
Ms. Ines Poeschel
Independent Director
Independent Director
12.08K
+15.09%
Ms. Lynn Dorsey Bleil
Ms. Lynn Dorsey Bleil
Independent Director
Independent Director
10.94K
+13.26%
Ms. Deborah Di Sanzo
Ms. Deborah Di Sanzo
Director
Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. David J. Endicott
Mr. David J. Endicott
Chief Executive Officer, Director
Chief Executive Officer, Director
207.11K
-11.08%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
134.23K
+38.34%
Mr. Rajkumar Narayanan
Mr. Rajkumar Narayanan
Senior Vice President, President - International
Senior Vice President, President - International
37.83K
+9.30%
Mr. Ian Bell
Mr. Ian Bell
Chief Operating Officer, Senior Vice President
Chief Operating Officer, Senior Vice President
30.23K
-24.88%
Ms. Karen J. May, CPA
Ms. Karen J. May, CPA
Independent Director
Independent Director
28.32K
+11.14%
Mr. Laurent Attias
Mr. Laurent Attias
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
22.62K
+15.19%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
By BusinessUSD
Name
Revenue
Proportion
Consumables
777.00M
30.15%
Contact lenses
692.00M
26.85%
Implantables
456.00M
17.69%
Ocular health
430.00M
16.69%
Equipment/other
222.00M
8.61%
Sales to Novartis Group
19.00M
0.74%
By RegionUSD
Name
Revenue
Proportion
International
1.42B
54.99%
United States
1.16B
45.01%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Consumables
777.00M
30.15%
Contact lenses
692.00M
26.85%
Implantables
456.00M
17.69%
Ocular health
430.00M
16.69%
Equipment/other
222.00M
8.61%
Sales to Novartis Group
19.00M
0.74%
Shareholding Stats
Updated: Thu, Nov 27
Updated: Thu, Nov 27
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Advisors (UK) Limited
4.94%
The Vanguard Group, Inc.
4.20%
UBS Fund Management (Switzerland) AG
2.29%
Norges Bank Investment Management (NBIM)
2.27%
Aristotle Capital Management, LLC
2.14%
Other
84.16%
Shareholders
Shareholders
Proportion
BlackRock Advisors (UK) Limited
4.94%
The Vanguard Group, Inc.
4.20%
UBS Fund Management (Switzerland) AG
2.29%
Norges Bank Investment Management (NBIM)
2.27%
Aristotle Capital Management, LLC
2.14%
Other
84.16%
Shareholder Types
Shareholders
Proportion
Investment Advisor
31.53%
Investment Advisor/Hedge Fund
24.78%
Bank and Trust
4.10%
Sovereign Wealth Fund
2.35%
Hedge Fund
2.09%
Research Firm
1.93%
Pension Fund
1.41%
Individual Investor
0.13%
Insurance Company
0.07%
Other
31.61%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
1623
342.44M
72.26%
+507.76K
2025Q3
1664
342.40M
72.42%
-9.24M
2025Q2
1658
350.50M
70.82%
+3.47M
2025Q1
1649
340.47M
77.49%
-46.78M
2024Q4
1637
370.92M
68.31%
+36.10M
2024Q3
1614
334.31M
67.55%
+3.20M
2024Q2
1581
336.83M
74.41%
-28.77M
2024Q1
1567
336.16M
66.45%
+4.09M
2023Q4
1583
325.43M
67.42%
+1.37M
2023Q3
1565
323.23M
69.34%
-9.13M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Advisors (UK) Limited
24.68M
4.94%
--
--
Dec 31, 2024
The Vanguard Group, Inc.
20.64M
4.13%
+781.14K
+3.93%
Jun 30, 2025
UBS Fund Management (Switzerland) AG
11.47M
2.29%
-68.71K
-0.60%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
11.35M
2.27%
-1.28M
-10.12%
Jun 30, 2025
Aristotle Capital Management, LLC
12.04M
2.41%
-191.15K
-1.56%
Jun 30, 2025
T. Rowe Price Associates, Inc.
6.98M
1.4%
+2.06M
+41.82%
Jun 30, 2025
Zürcher Kantonalbank (Asset Management)
9.14M
1.83%
+628.34K
+7.38%
Jun 30, 2025
AKO Capital LLP
7.71M
1.54%
+597.84K
+8.40%
Jun 30, 2025
Fidelity Management & Research Company LLC
10.21M
2.04%
-4.82M
-32.06%
Jun 30, 2025
Select Equity Group, L.P.
6.76M
1.35%
+1.28M
+23.44%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Global X Aging Population ETF
2.36%
Franklin FTSE Switzerland ETF
2.28%
iShares MSCI Switzerland ETF
2.2%
First Trust Indxx Medical Devices ETF
2.06%
Running Oak Efficient Growth ETF
1.77%
Global X S&P Catholic Values Developed ex-US ETF
1.07%
JPMorgan BetaBuilders Europe ETF
0.59%
iShares Global Healthcare ETF
0.53%
ALPS O'Shares International Developed Quality Dividend ETF
0.45%
Wahed Dow Jones Islamic World ETF
0.44%
View more
Global X Aging Population ETF
Proportion2.36%
Franklin FTSE Switzerland ETF
Proportion2.28%
iShares MSCI Switzerland ETF
Proportion2.2%
First Trust Indxx Medical Devices ETF
Proportion2.06%
Running Oak Efficient Growth ETF
Proportion1.77%
Global X S&P Catholic Values Developed ex-US ETF
Proportion1.07%
JPMorgan BetaBuilders Europe ETF
Proportion0.59%
iShares Global Healthcare ETF
Proportion0.53%
ALPS O'Shares International Developed Quality Dividend ETF
Proportion0.45%
Wahed Dow Jones Islamic World ETF
Proportion0.44%
Dividend
A total of
400.00M
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Mar 01, 2022
ALC.NB Final Cash Dividend of gross CHF 0.2 paid on May 05, 2022 going ex on Apr 29, 2022
May 04, 2022
May 05, 2022
May 03, 2022
Feb 24, 2021
ALC.NB Final Cash Dividend of gross CHF 0.1 paid on May 06, 2021 going ex on May 04, 2021
May 05, 2021
May 06, 2021
May 04, 2021
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Alcon AG?
The top five shareholders of Alcon AG are:
BlackRock Advisors (UK) Limited holds 24.68M shares, accounting for 4.94% of the total shares.
The Vanguard Group, Inc. holds 20.64M shares, accounting for 4.13% of the total shares.
UBS Fund Management (Switzerland) AG holds 11.47M shares, accounting for 2.29% of the total shares.
Norges Bank Investment Management (NBIM) holds 11.35M shares, accounting for 2.27% of the total shares.
Aristotle Capital Management, LLC holds 12.04M shares, accounting for 2.41% of the total shares.
BlackRock Advisors (UK) Limited holds 24.68M shares, accounting for 4.94% of the total shares.
The Vanguard Group, Inc. holds 20.64M shares, accounting for 4.13% of the total shares.
UBS Fund Management (Switzerland) AG holds 11.47M shares, accounting for 2.29% of the total shares.
Norges Bank Investment Management (NBIM) holds 11.35M shares, accounting for 2.27% of the total shares.
Aristotle Capital Management, LLC holds 12.04M shares, accounting for 2.41% of the total shares.
What are the top three shareholder types of Alcon AG?
The top three shareholder types of Alcon AG are:
BlackRock Advisors (UK) Limited
The Vanguard Group, Inc.
UBS Fund Management (Switzerland) AG
BlackRock Advisors (UK) Limited
The Vanguard Group, Inc.
UBS Fund Management (Switzerland) AG
How many institutions hold shares of Alcon AG (ALC)?
As of 2025Q4, 1623 institutions hold shares of Alcon AG, with a combined market value of approximately 342.44M, accounting for 72.26% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -0.16%.
What is the biggest source of revenue for Alcon AG?
In FY2025Q2, the Consumables business generated the highest revenue for Alcon AG, amounting to 777.00M and accounting for 30.15% of total revenue.
